CRISPR

CRISPR2-smad3b

ID
ZDB-CRISPR-260928-1
Name
CRISPR2-smad3b
Previous Names
None
Target
Sequence
5' - GGGATGGAGTAATCATCTAG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
zf4413 smad3b
Expression
Gene expression in Wild Types + CRISPR2-smad3b
No data available
Phenotype
Phenotype resulting from CRISPR2-smad3b
No data available
Phenotype of all Fish created by or utilizing CRISPR2-smad3b
Phenotype Fish Conditions Figures
ventral aorta increased diameter, abnormal smad3asa2363/+; smad3bzf4413/zf4413; y1Tg (AB) standard conditions Fig. 2 from Vanhooydonck et al., 2026
ventral aorta increased diameter, abnormal smad3asa2363/sa2363; smad3bzf4413/zf4413; y1Tg (AB) standard conditions Fig. 2 from Vanhooydonck et al., 2026
ventral aorta decreased diameter, abnormal smad3asa2363/+; smad6azf4414/+; smad6bzf4415/zf4415; smad3bzf4413/zf4413; y1Tg (AB) standard conditions Fig. 2 from Vanhooydonck et al., 2026
ventriculo bulbo valve hypertrophic, abnormal smad3asa2363/sa2363; smad6azf4414/zf4414; smad6bzf4415/zf4415; smad3bzf4413/zf4413; y1Tg (AB) standard conditions Fig. 4 from Vanhooydonck et al., 2026
ventriculo bulbo valve morphology, abnormal smad3asa2363/sa2363; smad6azf4414/zf4414; smad6bzf4415/zf4415; smad3bzf4413/zf4413; y1Tg (AB) standard conditions Fig. 4 from Vanhooydonck et al., 2026
whole organism viability, ameliorated smad3asa2363/sa2363; smad6azf4414/zf4414; smad6bzf4415/zf4415; smad3bzf4413/zf4413; y1Tg (AB) standard conditions Fig. 3 from Vanhooydonck et al., 2026
atrioventricular valve hypertrophic, abnormal smad3asa2363/sa2363; smad6azf4414/zf4414; smad6bzf4415/zf4415; smad3bzf4413/zf4413; y1Tg (AB) standard conditions Fig. 4 from Vanhooydonck et al., 2026
atrioventricular valve morphology, abnormal smad3asa2363/sa2363; smad6azf4414/zf4414; smad6bzf4415/zf4415; smad3bzf4413/zf4413; y1Tg (AB) standard conditions Fig. 4 from Vanhooydonck et al., 2026
ventral aorta decreased diameter, abnormal smad3asa2363/sa2363; smad6azf4414/zf4414; smad6bzf4415/zf4415; smad3bzf4413/zf4413; y1Tg (AB) standard conditions Fig. 2 from Vanhooydonck et al., 2026
ventral aorta morphology, abnormal smad3asa2363/sa2363; smad6azf4414/zf4414; smad6bzf4415/zf4415; smad3bzf4413/zf4413; y1Tg (AB) standard conditions Fig. 3 from Vanhooydonck et al., 2026
Citations